Diabetic eye disease: open trials in Germany

• NCT06321302

  A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

  Trial Treatment · Phase 2 · Boehringer Ingelheim

  Universitaetsklinikum Bonn AöR, Bonn · Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz · Diakonie Klinikum Dietrich Bonhoeffer GmbH, Neubrandenburg · Universitaetsklinikum Tuebingen AöR, Tuebingen · Universitaetsklinikum Ulm AoR, Ulm

  Registry updated 2026-10-28

• NCT06962839

  A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  Trial Treatment · Phase 2 · Boehringer Ingelheim

  Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR, Dresden · Universitaetsklinikum Duesseldorf AöR, Duesseldorf · Universitaet Leipzig, Leipzig · Heidelberg University, Mannheim · Augenzentrum Am St Franziskus-Hospital Muenster, Munster

  Registry updated 2026-10-16

• NCT05704491

  AI Screening for Diabetic Retinopathy

  Research · West German Center of Diabetes and Health

  West German Center of Diabetes and Health, Düsseldorf

  Registry updated 2026-08-10

• NCT07308639

  DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

  Research · Bayer

  Bayer Vital GmbH, Leverkusen

  Registry updated 2026-06-22

• NCT07378891

  Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)

  Research · University Hospital Tuebingen

  University Hospital Tuebingen, Dep. Diabetology, Tübingen

  Registry updated 2026-02-10

• NCT06124586

  Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

  Trial Treatment · Heinrich-Heine University, Duesseldorf

  University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine, Düsseldorf

  Registry updated 2026-02-04

• NCT07259928

  Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

  Trial Treatment · Phase 2 · Annexin Pharmaceuticals AB

  Universitaetsklinikum Tuebingen AöR, Tuebingen

  Registry updated 2025-12-02

All Diabetic eye disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error